MatchPlay
Venture Capital And Private Equity Principals
The Challenge of Objectively Measuring Pain—especially in Non-verbal Patients.
13 employees
- Employees
- 13
- Contacts
- 3
- Emails
- 3
- Phones
- 2
MatchPlay Overview
- Headquarters
- The Challenge of Objectively Measuring Pain—especially in Non-verbal Patients.
- Website
- www.matchplaygroup.com
- Industry
- Venture Capital And Private Equity Principals
- Employees
- 13
- NAICS
-
Miscellaneous Intermediation
Keywords
About MatchPlay
MatchPlay matches founders directly to the things they need most, such as mentors, investors, accelerators and more. The best part? All these resources are provided at NO COST, recognizing the crucial need for startups to access constructive tools and partnerships to scale effectively.
MatchPlay Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 2
- 50.0% coverage
MatchPlay Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Austin Evans | Outdated Tools. No Real Process. Big | Houston, Texas, United States |
Email
Phone
|
| Caitlin Marcelino (West), Mba | Founder - Finance - Adjunct Professor | Philadelphia, Pennsylvania, United States |
Email
Phone
|
| Reno Navales | Founder @ Renowned - Bdr @ Eventbrite | Marina, California, United States |
Email
|
| Fernando Moreno | Fractional CFO - Michigan Ross Mba | Austin, Texas, United States |
View
|
Employees by Management Level
Executive
3 profiles
Individual contributor
1 profile
Compare Similar Companies to MatchPlay
Lowenstein Sandler LLP
Law Practice
Sputnik ATX VC
Venture Capital And Private Equity Principals
Lamarka
Business Consulting And Services
What If Ventures
Venture Capital And Private Equity Principals
ASTRALABS
Venture Capital And Private Equity Principals
iRxReminder LLC
Pharmaceutical Manufacturing
Superorganism
Venture Capital And Private Equity Principals
Vulcan Growth Partners
Business Consulting And Services
Neuvation Ventures
Venture Capital And Private Equity Principals
PepVax
Biotechnology